{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T20:19:39Z","timestamp":1680207579271},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CHDDT"],"published-print":{"date-parts":[[2006,9,1]]},"DOI":"10.2174\/187152906778249554","type":"journal-article","created":{"date-parts":[[2008,4,17]],"date-time":"2008-04-17T20:44:03Z","timestamp":1208465043000},"page":"209-217","source":"Crossref","is-referenced-by-count":5,"title":["Novel Agents to Manage Dyslipidemias and Impact Atherosclerosis"],"prefix":"10.2174","volume":"6","author":[{"given":"S.","family":"Nachimuthu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Raggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Cardiovascular &amp; Hematological Disorders-Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/57802","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T09:54:09Z","timestamp":1448272449000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1871-529X&volume=6&issue=3&spage=209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,1]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/187152906778249554","relation":{},"ISSN":["1871-529X"],"issn-type":[{"value":"1871-529X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9,1]]}}}